Email this article Using Coherent Spectroscopy for Diagnosing Cancer at Its Early Stages
- Authors: Moguilnaya T.Y.1,2, Botikov A.G.2,3, Agibalov A.A.2
-
Affiliations:
- AO Tekhnoimport
- ZAO SERVET
- Gamaleya National Research Center of Epidemiology and Microbiology
- Issue: Vol 82, No 8 (2018)
- Pages: 1052-1056
- Section: Proceedings of the XII International Scientific School-Seminar “Fundamental Research and Innovation: Nanooptics, Photonics, and Coherent Spectroscopy”
- URL: https://journals.rcsi.science/1062-8738/article/view/186058
- DOI: https://doi.org/10.3103/S1062873818080312
- ID: 186058
Cite item
Open Access
Access granted
Subscription Access
Abstract
A new automated way of monitoring oncological diseases that combines forced luminescence and stimulated Brillouin scattering is proposed. Characteristics are studied of the transmission spectra of human colorectal (HT-29) and human cervical (HeLa) adenocarcinoma cells and tumor markers for PCR in water at the amounts needed for initial identification with 95% probability. The results are used to create a model of a device for monitoring oncology at its early stages.
About the authors
T. Yu. Moguilnaya
AO Tekhnoimport; ZAO SERVET
Author for correspondence.
Email: mogilnay@mail.ru
Russian Federation, Moscow, 115522; Moscow, 123022
A. G. Botikov
ZAO SERVET; Gamaleya National Research Center of Epidemiology and Microbiology
Email: mogilnay@mail.ru
Russian Federation, Moscow, 123022; Moscow, 123098
A. A. Agibalov
ZAO SERVET
Email: mogilnay@mail.ru
Russian Federation, Moscow, 123022
Supplementary files
